STERIS provides infection prevention, sterilization, and procedural products and services for hospitals, surgery centers, and other healthcare and life-science settings. Its portfolio includes sterilizers, surgical tables and lights, instrument cleaning and reprocessing systems, and related consumables and service contracts. Customers rely on the company for regulatory-compliant sterile processing and operating-room infrastructure rather than pharmaceuticals.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 1,391.1 | — | 177.4 | -12.7% |
| Q3 2025 | 1,460.3 | — | 191.9 | -9.1% |
| Q4 2025 | 1,496.2 | — | 192.9 | -15.8% |
| Q1 2026 | 1,588.4 | — | 220.2 | -18.2% |
| Q2 2026 | 1,492.7 | 7.3% | 200.1 | 12.8% |
All markets — KeepWinning global stock screener
Other companies on NYSE: US Foods Holding Corp. (USFD), Sociedad Química y Minera de Chile S.A. (SQM), Markel Group Inc. (MKL), Bunge Global SA (BG), Constellation Brands, Inc. (STZ), Equifax Inc. (EFX)